Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2007 2
2008 6
2009 3
2010 9
2011 4
2012 5
2013 5
2014 8
2015 3
2016 5
2017 5
2018 3
2019 12
2020 8
2021 19
2022 8
2023 14
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

101 results

Results by year

Filters applied: . Clear all
Page 1
Outpatient glucocorticoid use and COVID-19 outcomes: a population-based study.
Rodríguez-Fernández A, Visos-Varela I, Zapata-Cachafeiro M, Pintos-Rodríguez S, García-Álvarez RM, Herdeiro TM, Piñeiro-Lamas M, Figueiras A, Salgado-Barreira Á; COVIDRUG Group. Rodríguez-Fernández A, et al. Inflammopharmacology. 2024 May 2. doi: 10.1007/s10787-024-01474-3. Online ahead of print. Inflammopharmacology. 2024. PMID: 38698179
Impact of prior antihypertensive treatment on COVID-19 outcomes, by active ingredient.
García-Álvarez RM, Zapata-Cachafeiro M, Visos-Varela I, Rodríguez-Fernández A, Pintos-Rodríguez S, Piñeiro-Lamas M, Herdeiro TM, Figueiras A, Salgado-Barreira A; COVID-Drug Group. García-Álvarez RM, et al. Inflammopharmacology. 2024 Apr 15. doi: 10.1007/s10787-024-01475-2. Online ahead of print. Inflammopharmacology. 2024. PMID: 38619761
Higher COVID-19 pneumonia risk associated with anti-IFN-α than with anti-IFN-ω auto-Abs in children.
Bastard P, Gervais A, Taniguchi M, Saare L, Särekannu K, Le Voyer T, Philippot Q, Rosain J, Bizien L, Asano T, Garcia-Prat M, Parra-Martínez A, Migaud M, Tsumura M, Conti F, Belot A, Rivière JG, Morio T, Tanaka J, Javouhey E, Haerynck F, Duvlis S, Ozcelik T, Keles S, Tandjaoui-Lambiotte Y, Escoda S, Husain M, Pan-Hammarström Q, Hammarström L, Ahlijah G, Abi Haidar A, Soudee C, Arseguel V, Abolhassani H, Sahanic S, Tancevski I, Nukui Y, Hayakawa S, Chrousos GP, Michos A, Tatsi EB, Filippatos F, Rodriguez-Palmero A, Troya J, Tipu I, Meyts I, Roussel L, Ostrowski SR, Schidlowski L, Prando C, Condino-Neto A, Cheikh N, Bousfiha AA, El Bakkouri J; COVID Clinicians; GEN-COVID Study Group; COVID Human Genetic Effort; Peterson P, Pujol A, Lévy R, Quartier P, Vinh DC, Boisson B, Béziat V, Zhang SY, Borghesi A, Pession A, Andreakos E, Marr N, Mentis AA, Mogensen TH, Rodríguez-Gallego C, Soler-Palacin P, Colobran R, Tillmann V, Neven B, Trouillet-Assant S, Brodin P, Abel L, Jouanguy E, Zhang Q, Martinón-Torres F, Salas A, Gómez-Carballa A, Gonzalez-Granado LI, Kisand K, Okada S, Puel A, Cobat A, Casanova JL. Bastard P, et al. J Exp Med. 2024 Feb 5;221(2):e20231353. doi: 10.1084/jem.20231353. Epub 2024 Jan 4. J Exp Med. 2024. PMID: 38175961 Free PMC article.
Comparison of Long-term Response and Remission to Omalizumab and Anti-IL-5/IL-5R Using Different Criteria in a Real-life Cohort of Severe Asthma Patients.
Valverde-Monge M, Sánchez-Carrasco P, Betancor D, Barroso B, Rodrigo-Muñoz JM, Mahillo-Fernández I, Arismendi E, Bobolea I, Cárdaba B, Cruz MJ, Del Pozo V, Domínguez-Ortega J, González-Barcala FJ, Olaguibel JM, Luna-Porta JA, Martínez-Rivera C, Mullol J, Muñoz X, Peleteiro-Pedraza L, Picado Valles C, Plaza V, Quirce S, Rial MJ, Soto-Retes L, Valero A, Sastre J. Valverde-Monge M, et al. Arch Bronconeumol. 2024 Jan;60(1):23-32. doi: 10.1016/j.arbres.2023.11.011. Epub 2023 Nov 22. Arch Bronconeumol. 2024. PMID: 38042707 English, Spanish.
Burden of refractory and unexplained chronic cough on patients' lives: a cohort study.
Puente-Maestu L, Dávila I, Quirce S, Crespo-Lessmann A, Martínez-Moragón E, Sola J, Nieto ML, González-Barcala FJ, Cea-Calvo L, Sánchez-Jareño M, Rivas-Pardinas C, Domingo C. Puente-Maestu L, et al. ERJ Open Res. 2023 Sep 25;9(5):00425-2023. doi: 10.1183/23120541.00425-2023. eCollection 2023 Sep. ERJ Open Res. 2023. PMID: 37753282 Free PMC article.
Allergic rhinitis and dental caries: A systematic review.
Calvo-Henriquez C, Rodríguez-Rivas P, Mayo-Yáñez M, González-Barcala FJ, Boronat-Catala B, Martins-Neves S, Martínez-Capoccioni G, Martin-Martin C. Calvo-Henriquez C, et al. Among authors: gonzalez barcala fj. Allergol Immunopathol (Madr). 2023 Sep 1;51(5):21-22. doi: 10.15586/aei.v51i5.957. eCollection 2023. Allergol Immunopathol (Madr). 2023. PMID: 37695225 No abstract available.
[FENO measurement devices].
Blanco-Aparicio M, González-Barcala FJ, Padilla Galo A. Blanco-Aparicio M, et al. Open Respir Arch. 2022 Sep 16;4(4):100207. doi: 10.1016/j.opresp.2022.100207. eCollection 2022 Oct-Dec. Open Respir Arch. 2022. PMID: 37496969 Free PMC article. Review. Spanish.
[A Study of the Prevalence of Asthma in the General Population in Spain].
Blanco-Aparicio M, García-Río FJ, González-Barcala FJ, Jiménez-Ruiz CA, Muñoz X, Plaza V, Soto-Campos JG, Urrutia-Landa I, Almonacid C, Peces-Barba G, Álvarez-Gutiérrez FJ. Blanco-Aparicio M, et al. Open Respir Arch. 2023 Apr 17;5(2):100245. doi: 10.1016/j.opresp.2023.100245. eCollection 2023 Apr-Jun. Open Respir Arch. 2023. PMID: 37496876 Free PMC article. Spanish.
[Consensus document for severe asthma in adults. 2022 update].
Alvarez-Gutiérrez FJ, Blanco-Aparicio M, Casas-Maldonado F, Plaza V, González-Barcala FJ, Carretero-Gracia JÁ, Castilla-Martínez M, Cisneros C, Diaz-Pérez D, Domingo-Ribas C, Martínez-Moragon E, Muñoz X, Padilla-Galo A, Perpiñá-Tordera M, Soto-Campos G. Alvarez-Gutiérrez FJ, et al. Open Respir Arch. 2022 Jul 2;4(3):100192. doi: 10.1016/j.opresp.2022.100192. eCollection 2022 Jul-Sep. Open Respir Arch. 2022. PMID: 37496585 Free PMC article. Spanish.
101 results